Published in J Natl Cancer Inst on March 03, 2004
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) (2008) 3.97
Helicobacter pylori in health and disease. Gastroenterology (2009) 3.84
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest (2009) 3.26
The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc Natl Acad Sci U S A (2006) 3.07
Environmental causes of esophageal cancer. Gastroenterol Clin North Am (2009) 2.80
Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis (2012) 1.84
Association between Helicobacter pylori and mortality in the NHANES III study. Gut (2013) 1.74
Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut (2005) 1.74
Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer (2008) 1.72
Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer (2006) 1.64
Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut (2007) 1.57
Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut (2007) 1.57
Intracellular Helicobacter pylori in gastric epithelial progenitors. Proc Natl Acad Sci U S A (2005) 1.47
Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc (2005) 1.37
Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg (2006) 1.24
Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut (2009) 1.23
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer (2006) 1.16
Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci (2014) 1.12
Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol (2012) 1.09
Helicobacter pylori infection and diabetes: is it a myth or fact? World J Gastroenterol (2014) 1.08
Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer (2009) 1.07
Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol Biomarkers Prev (2014) 1.07
H pylori and gastric cancer: shifting the global burden. World J Gastroenterol (2006) 1.05
Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology (2010) 1.03
Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer (2011) 1.00
Sex-specific risk factor profile in oesophageal adenocarcinoma. Br J Cancer (2008) 0.99
Helicobacter pylori and oesophageal cancer--not always protective. Gut (2007) 0.98
Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One (2011) 0.97
Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter (2008) 0.97
Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort. Br J Cancer (2011) 0.95
Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Etiologic factors of gastric cardiac adenocarcinoma among men in Taiwan. World J Gastroenterol (2009) 0.94
Gastric hyposecretion in esophageal squamous-cell carcinomas. Dig Dis Sci (2009) 0.93
Response of gastric epithelial progenitors to Helicobacter pylori Isolates obtained from Swedish patients with chronic atrophic gastritis. J Biol Chem (2009) 0.93
Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population. Oncotarget (2015) 0.92
The changing face of esophageal cancer. Cancers (Basel) (2010) 0.92
Barrett esophagus: an update. Nat Rev Gastroenterol Hepatol (2010) 0.92
Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J Gastroenterol (2013) 0.91
Familial risk for gastric carcinoma: an updated study from Sweden. Br J Cancer (2007) 0.88
Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. Cancer Epidemiol Biomarkers Prev (2011) 0.88
Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus. Neoplasia (2012) 0.88
Gastroesophageal reflux disease: Important considerations for the older patients. World J Gastrointest Endosc (2010) 0.87
PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population. Oncotarget (2016) 0.86
Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit. Br J Cancer (2012) 0.86
Association between Helicobacter pylori seropositivity and digestive tract cancers. World J Gastroenterol (2009) 0.86
Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers. Gut (2006) 0.85
Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan. BMC Gastroenterol (2009) 0.85
Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev (2014) 0.85
Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection. Clin Vaccine Immunol (2008) 0.84
Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea. Gut Liver (2010) 0.83
Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis. World J Gastroenterol (2006) 0.83
Ethnic differences in gastric cancer genetic susceptibility: allele flips of interleukin gene. World J Gastroenterol (2014) 0.81
Atrophic gastritis: risk factor for esophageal squamous cell carcinoma in a Latin-American population. World J Gastroenterol (2013) 0.81
Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study. BMC Gastroenterol (2009) 0.81
Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone. Therap Adv Gastroenterol (2008) 0.81
Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis. PLoS One (2013) 0.80
Oesophageal cancer mortality in Spain: a spatial analysis. BMC Cancer (2007) 0.80
Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status. Carcinogenesis (2014) 0.79
Microbial biofilms and gastrointestinal diseases. Pathog Dis (2013) 0.79
Estimating disease prevalence using census data. Epidemiol Infect (2007) 0.78
Genetic variant rs4072037 of MUC1 and gastric cancer risk in an Eastern Chinese population. Oncotarget (2016) 0.78
Dietary proportions of carbohydrates, fat, and protein and risk of oesophageal cancer by histological type. PLoS One (2013) 0.77
Risk factors associated with Barrett's epithelial dysplasia. World J Gastroenterol (2014) 0.77
Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori. Infect Immun (2013) 0.77
Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front Microbiol (2015) 0.77
Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci Rep (2015) 0.77
Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation. Cancer Causes Control (2013) 0.76
H pylori receptor MHC class II contributes to the dynamic gastric epithelial apoptotic response. World J Gastroenterol (2006) 0.76
Expression, purification and characterization of arginase from Helicobacter pylori in its apo form. PLoS One (2011) 0.76
Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer? United European Gastroenterol J (2014) 0.76
Overview of esophageal cancer. Ann Cardiothorac Surg (2017) 0.75
H. pylori receptor MHC class II contributes to the dynamic gastric epithelial apoptotic response. World J Gastroenterol (2006) 0.75
Restriction fragment length polymorphism of adhesin gene hpaA from different Helicobacter pylori strains of Chongqing, China. World J Gastroenterol (2005) 0.75
Elevated levels of adaption in Helicobacter pylori genomes from Japan; a link to higher incidences of gastric cancer? Evol Med Public Health (2015) 0.75
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma. Clinics (Sao Paulo) (2017) 0.75
Association between the expression levels of tumor necrosis factor-α-induced protein 8 and the prognosis of patients with gastric adenocarcinoma. Exp Ther Med (2016) 0.75
Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol (2017) 0.75
Helicobacter pylori Infection and Upper Gastrointestinal Disorders. Gastroenterol Res Pract (2013) 0.75
Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma. Semin Oncol (2015) 0.75
Arginase of Helicobacter Gastric Pathogens Uses a Unique Set of Non-catalytic Residues for Catalysis. Biophys J (2017) 0.75
Genetic variant of miR-146a rs2910164 C>G and gastric cancer susceptibility. Oncotarget (2016) 0.75
Enigmas, priorities and opportunities in cancer epidemiology. Eur J Epidemiol (2017) 0.75
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29
The false-positive to false-negative ratio in epidemiologic studies. Epidemiology (2011) 4.93
Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut (2013) 4.29
Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol (2011) 4.10
The epidemiology of renal cell carcinoma. J Urol (2006) 3.85
Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet (2007) 3.84
False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst (2008) 3.72
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc (2005) 3.67
Obesity and risk for chronic renal failure. J Am Soc Nephrol (2006) 3.67
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
Cancer risk among statin users: a population-based cohort study. Int J Cancer (2005) 3.50
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One (2010) 3.45
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst (2006) 3.36
Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med (2003) 3.30
'Environment' in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis (2007) 3.20
Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07
The landscape of recombination in African Americans. Nature (2011) 3.06
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med (2003) 3.04
Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect (2007) 3.03
Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet (2007) 3.00
Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Clin Oncol (2009) 2.95
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis (2009) 2.85
Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol (2006) 2.65
The Southern Community Cohort Study: investigating health disparities. J Health Care Poor Underserved (2010) 2.44
Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol (2014) 2.41
A further plea for adherence to the principles underlying science in general and the epidemiologic enterprise in particular. Int J Epidemiol (2009) 2.35
Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst (2006) 2.33
Albumin and C-reactive protein levels predict short-term mortality after percutaneous endoscopic gastrostomy in a prospective cohort study. Gastrointest Endosc (2010) 2.28
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res (2006) 2.24
Comparing diabetes prevalence between African Americans and Whites of similar socioeconomic status. Am J Public Health (2007) 2.24
Review of epidemiologic studies of dietary acrylamide intake and the risk of cancer. Eur J Cancer Prev (2012) 2.19
Increased risk of colorectal cancer after obesity surgery. Ann Surg (2013) 2.17
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13
Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial. BMJ (2010) 2.11
Carbonated soft drink consumption and risk of esophageal adenocarcinoma. J Natl Cancer Inst (2006) 2.08
Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut (2013) 2.04
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 2.01
The Björk-Shiley convexo-concave heart valve experience from the perspective of the supervisory panel. Am J Cardiol (2013) 2.00
A rebuttal: secret ties to industry and conflicting interests in cancer research. Am J Ind Med (2007) 1.99
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood (2010) 1.98
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology (2006) 1.98
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med (2005) 1.98
The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis (2005) 1.97
Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev (2009) 1.90
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 1.88
Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control (2008) 1.86
Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther (2002) 1.82
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control (2005) 1.80
Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst (2003) 1.79
Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology (2002) 1.76
Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men. J Gen Intern Med (2011) 1.76
Risk factors for long-term pain after hernia surgery. Ann Surg (2006) 1.74
A population-based study showing an association between gastroesophageal reflux disease and sleep problems. Clin Gastroenterol Hepatol (2009) 1.71
A cohort mortality study among titanium dioxide manufacturing workers in the United States. J Occup Environ Med (2003) 1.70
Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst (2003) 1.68
SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog (2006) 1.68
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol (2006) 1.64
Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol (2009) 1.64
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst (2010) 1.60
Risk of lung cancer and residential radon in China: pooled results of two studies. Int J Cancer (2004) 1.60
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res (2011) 1.59
Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer (2006) 1.59
Maternal caffeine consumption and spontaneous abortion: a review of the epidemiologic evidence. Epidemiology (2004) 1.57
A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat (2006) 1.57
Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod (2009) 1.56
Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 1.55
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet (2011) 1.54
Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol (2010) 1.54
Duration of red blood cell storage and survival of transfused patients (CME). Transfusion (2010) 1.53
Estimating nutrient intake from a food frequency questionnaire: incorporating the elements of race and geographic region. Am J Epidemiol (2009) 1.53
Lung cancer risk among smokers of menthol cigarettes. J Natl Cancer Inst (2011) 1.50
Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg (2010) 1.50
Complications after percutaneous endoscopic gastrostomy in a prospective study. Scand J Gastroenterol (2012) 1.49
Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol (2013) 1.48
Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer (2008) 1.48
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47
Risk factors for esophageal adenocarcinoma after antireflux surgery. Ann Surg (2013) 1.44
Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg (2006) 1.44